US grant applicants surge at prestigious European research agency www.nature.com/articles/d41...
youtube.com/watch?v=Fd-_...
2025: an annus horribilis for health in the USA - The Lancet www.thelancet.com/journals/lan...
New postdoc position available in the Heczey lab focused on state-of-the-art bioengineering.
seattlechildrens.wd5.myworkdayjobs.com/en-US/Extern...
Feasibility and safety of cellular therapy for in-utero repair of myelomeningocele (CuRe Trial): a first-in-human, phase 1, single-arm study - The Lancet www.thelancet.com/journals/lan...
‘Shattered’: US scientists speak out about how Trump policies disrupted their careers www.nature.com/articles/d41...
www.wsj.com/opinion/athl...
From The Economist: What our analysis of 900 firms shows about their values
www.economist.com/interactive/...
share.google/PlYzKjubZL0p...
Discussions are ongoing about new academic models. Here is one idea.
A flood of Chinese graduate students in STEM was a boon to U.S. students | Science | AAAS www.science.org/content/arti...
www.thelancet.com
This first-in-human treatment consisting of allogeneic, live stem cells showed no
cell-related adverse effects. The therapy was assessed as sufficiently safe to proceed
with non-staggered enrolment of...
The US Advisory Committee on Immunization Practices vote on Dec 5 to no longer recommend
the hepatitis B vaccine birth dose, which had ensured that babies exposed to hepatitis
B would not later develo...
www.thelancet.com
The Heczey Lab believes that the development of the next-generation of cell therapies will be based on in-vivo (inside the body) genetic engineering of cells which can overcome the immune escape mecha...
Some innovative higher-education institutions are reimagining pedagogy by prioritizing local needs over research and international student recruitment. Anna McKie visits one of them.
